Identification of an episignature for the MEF2C-associated syndrome
- 25 November 2025
- journal article
- research article
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 34 (1) , 53-60
Abstract
Neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language (NEDHSIL), also known as MEF2C-related disorder or MEF2C haploinsufficiency syndrome (MCHS), is a condition caused by pathogenic variants in the Myocyte Enhancer Factor-2C (MEF2C) gene. This study aimed to identify a DNA methylation episignature specific to NEDHSIL and explore its similarities with other known episignatures. Genome-wide DNA levels were assessed in a cohort of patients with MEF2C mutations and controls, and differentially methylated CpG sites were identified. A bioinformatic analysis yielded a classifier that was trained against controls and other known episignature disorders within the EpiSign Knowledge Database. The classifier demonstrated high accuracy, sensitivity, and specificity in classifying NEDHSIL samples. Furthermore, functional annotation and comparative analysis revealed similarities between the NEDHSIL episignature and other genetic neurodevelopmental disorders. This study provides evidence for a DNA methylation episignature specific to NEDHSIL and highlights the potential utility of this epigenetic biomarker for diagnosing and understanding molecular pathophysiology of neurodevelopmental disorders associated with MEF2C mutations.Keywords
Funding Information
- Government of Canada through Genome Canada and the Ontario Genomics Institute - OGI-188
This publication has 45 references indexed in Scilit:
- Functional correlation of genome‐wide DNA methylation profiles in genetic neurodevelopmental disordersHuman Mutation, 2022
- Non-coding region variants upstream of MEF2C cause severe developmental disorder through three distinct loss-of-function mechanismsThe American Journal of Human Genetics, 2021
- Identification of a novel mutation in MEF2C gene in an atypical patient with frontotemporal lobar degenerationNeurological Sciences, 2021
- Evaluation of DNA Methylation Episignatures for Diagnosis and Phenotype Correlations in 42 Mendelian Neurodevelopmental DisordersThe American Journal of Human Genetics, 2020
- Diagnostic Utility of Genome-wide DNA Methylation Testing in Genetically Unsolved Individuals with Suspected Hereditary ConditionsThe American Journal of Human Genetics, 2019
- Genomic DNA Methylation Signatures Enable Concurrent Diagnosis and Clinical Genetic Variant Classification in Neurodevelopmental SyndromesThe American Journal of Human Genetics, 2018
- MEF2C Haploinsufficiency features consistent hyperkinesis, variable epilepsy, and has a role in dorsal and ventral neuronal developmental pathwaysneurogenetics, 2013
- SHANK3 as an autism spectrum disorder-associated geneBrain and Development, 2013
- Refining the phenotype associated with MEF2C point mutationsneurogenetics, 2012
- Integrated Transcript and Genome Analyses Reveal NKX2-1 and MEF2C as Potential Oncogenes in T Cell Acute Lymphoblastic LeukemiaCancer Cell, 2011